- βCovers multiple drug classes giving readers several options to explore
- βIncludes both injectable and oral alternatives for different patient preferences
- βProvides practical advice on how to speak with a doctor about switching medications
Why Is There Still an Ozempic Shortage in 2025?
The demand for semaglutide-based medications like Ozempic has skyrocketed over the past few years, driven by its dual use for type 2 diabetes management and weight loss. Despite manufacturer Novo Nordisk ramping up production, supply chain issues and unprecedented demand have kept Ozempic intermittently unavailable at many pharmacies across the United States. If your prescription has been delayed or denied, you are not alone β and more importantly, you have options.
Understanding What Ozempic Does
Ozempic (semaglutide) is a GLP-1 receptor agonist. It works by stimulating insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite. These combined effects make it highly effective at lowering A1C levels and supporting weight management in people with type 2 diabetes. When looking for alternatives, your doctor will try to match as many of these benefits as possible.
Top Ozempic Alternatives to Discuss With Your Doctor
1. Mounjaro (Tirzepatide)
Mounjaro is currently one of the strongest alternatives available. It acts on both GLP-1 and GIP receptors, making it a dual-agonist that can outperform Ozempic in A1C reduction and weight loss in clinical trials. While it was also facing some supply constraints, availability has improved significantly in 2025. Ask your endocrinologist whether tirzepatide is right for your situation.
2. Trulicity (Dulaglutide)
Trulicity is another GLP-1 receptor agonist administered once weekly, similar to Ozempic. While it may not produce the same degree of weight loss, it is well-tolerated and widely available. Many patients transitioning from Ozempic to Trulicity have maintained solid blood sugar control with minimal adjustment.
3. Victoza or Saxenda (Liraglutide)
Liraglutide is a daily injectable GLP-1 agonist. Victoza is the diabetes formulation, while Saxenda is dosed higher for weight management. It has a long safety record and remains widely available in 2025. The daily dosing schedule may be less convenient, but it offers a reliable option for those who cannot access semaglutide.
4. Rybelsus (Oral Semaglutide)
Interestingly, Rybelsus is the oral tablet form of the same active ingredient in Ozempic β semaglutide. Because it is a different formulation with a separate supply chain, it has experienced fewer shortages. If you prefer avoiding injections altogether, Rybelsus may be an ideal bridge solution. Availability can vary, so confirm with your pharmacy.
5. SGLT-2 Inhibitors (Jardiance, Farxiga)
If GLP-1 agonists remain inaccessible, SGLT-2 inhibitors are a powerful class of oral medications worth considering. Drugs like empagliflozin (Jardiance) and dapagliflozin (Farxiga) lower blood sugar by causing the kidneys to excrete excess glucose. They also provide cardiovascular and kidney-protective benefits β a meaningful bonus for many type 2 diabetics.
What You Should Never Do During a Medication Shortage
Do not abruptly stop managing your blood sugar if your prescription runs out. Uncontrolled blood glucose levels can lead to serious short- and long-term complications including neuropathy, retinopathy, and cardiovascular disease. Contact your healthcare provider immediately to explore the alternatives listed above. Resources like mdsdiabetes.com can also help you stay informed about the latest guidance on diabetes medications and shortage updates.
How to Talk to Your Doctor About Switching
When you speak with your physician, bring your most recent A1C results, a list of current medications, and any concerns about cost or insurance coverage. Ask specifically whether your new medication requires a prior authorization, as this can delay access by days or even weeks. Telehealth appointments have made these consultations faster and more accessible than ever before.
Final Thoughts
The Ozempic shortage is frustrating, but 2025 brings more alternatives than ever before. Whether you switch to tirzepatide, liraglutide, or an oral option, effective diabetes management remains entirely within reach. Work closely with your care team and stay proactive β your long-term health depends on consistent treatment, not a single brand name.